Influenza Vaccination and Guillain-Barré Syndrome: Reality or Fear
- PMID: 32010599
- PMCID: PMC6985921
- DOI: 10.2478/jtim-2019-0028
Influenza Vaccination and Guillain-Barré Syndrome: Reality or Fear
Abstract
Guillain-Barré syndrome (GBS) is an inflammatory disorder and an acute immune-mediated demyelinating neuropathy that causes reduced signal transmissions, progressive muscle weakness, and paralysis. The etiology of the syndrome still remains controversial and uncertain. GBS can be initiated and triggered by respiratory tract infections such as influenza, and intestinal infections such as Campylobacter jejuni. In addition, there is considerable evidence suggesting links between influenza vaccination and GBS. As reported previously, the incidence of GBS in individuals receiving swine flu vaccine was about one to two cases per million. Despite the influenza vaccine efficacy, its association with an immune-mediated demyelinating process can be challenging as millions of people get vaccinated every year. In this review we will discuss the association between influenza infection and vaccination with GBS by focusing on the possible immunopathological mechanisms.
Keywords: Guillain–Barré syndrome; flu vaccination; influenza.
© 2019 Arefeh Babazadeh et al., published by Sciendo.
Conflict of interest statement
Conflict of Interest There are no conflicts of interest.
Similar articles
-
Exploring the "Two-Hit" Phenomenon of Guillain-Barré Syndrome Following Respiratory Syncytial Virus and Influenza Vaccinations.Cureus. 2024 Sep 7;16(9):e68899. doi: 10.7759/cureus.68899. eCollection 2024 Sep. Cureus. 2024. PMID: 39246641 Free PMC article.
-
Surveillance for Guillain-Barré syndrome after 2015-2016 and 2016-2017 influenza vaccination of Medicare beneficiaries.Vaccine. 2019 Oct 8;37(43):6543-6549. doi: 10.1016/j.vaccine.2019.08.045. Epub 2019 Sep 9. Vaccine. 2019. PMID: 31515146
-
Near real-time surveillance for Guillain-Barré syndrome after influenza vaccination among the Medicare population, 2010/11 to 2013/14.Vaccine. 2017 May 19;35(22):2986-2992. doi: 10.1016/j.vaccine.2017.03.087. Epub 2017 Apr 24. Vaccine. 2017. PMID: 28449973
-
Guillain-Barre syndrome, influenza, and influenza vaccination: the epidemiologic evidence.Clin Infect Dis. 2014 Apr;58(8):1149-55. doi: 10.1093/cid/ciu005. Epub 2014 Jan 9. Clin Infect Dis. 2014. PMID: 24415636 Review.
-
Guillain-Barré syndrome after exposure to influenza virus.Lancet Infect Dis. 2010 Sep;10(9):643-51. doi: 10.1016/S1473-3099(10)70140-7. Lancet Infect Dis. 2010. PMID: 20797646 Review.
Cited by
-
Guillain-Barre syndrome following the first dose of the chimpanzee adenovirus-vectored COVID-19 vaccine, ChAdOx1.BMJ Case Rep. 2021 Apr 22;14(4):e242956. doi: 10.1136/bcr-2021-242956. BMJ Case Rep. 2021. PMID: 33888484 Free PMC article.
-
Serious neurological adverse events following immunization against SARS-CoV-2: a narrative review of the literature.Ther Adv Drug Saf. 2023 May 21;14:20420986231165674. doi: 10.1177/20420986231165674. eCollection 2023. Ther Adv Drug Saf. 2023. PMID: 37223456 Free PMC article. Review.
-
Incident changes in the prevalence of influenza type A virus among children before and after COVID-19 pandemic in Hangzhou, China.Clin Respir J. 2023 Jul;17(7):701-703. doi: 10.1111/crj.13659. Epub 2023 Jun 29. Clin Respir J. 2023. PMID: 37385422 Free PMC article. No abstract available.
-
Neurologic Safety Monitoring of COVID-19 Vaccines: Lessons From the Past to Inform the Present.Neurology. 2021 Oct 19;97(16):767-775. doi: 10.1212/WNL.0000000000012703. Epub 2021 Sep 2. Neurology. 2021. PMID: 34475124 Free PMC article. Review.
-
Vaccine Hesitancy: Contemporary Issues and Historical Background.Vaccines (Basel). 2022 Sep 22;10(10):1595. doi: 10.3390/vaccines10101595. Vaccines (Basel). 2022. PMID: 36298459 Free PMC article. Review.
References
-
- Goodfellow JA, Willison HJ. Guillain–Barré syndrome: a century of progress. Nat Rev Neurol. 2016;12:723–31. - PubMed
-
- Jasti AK, Selmi C, Sarmiento-Monroy JC, Vega DA, Anaya J-M, Gershwin ME. Guillain-Barré syndrome: causes, immunopathogenic mechanisms and treatment. Expert Rev Clin Immunol. 2016;12:1175–89. - PubMed
-
- Tandel H, Vanza J, Pandya N, Jani P. Guillain-barré syndrome (GBS) A Review. 2016:366–71.
Publication types
LinkOut - more resources
Full Text Sources
Research Materials